Read + Share
Amedeo Smart
Independent Medical Education
O'Kelly B, McGettrick P, Angelov D, Fay MP, et al. Outcome of a patient with refractory Hodgkin's Lymphoma on pembrolizumab, infected with SARS-CoV-2. Br J Haematol 2020 May 7. doi: 10.1111/bjh.16798.PMID: 32379903
Email
LinkedIn
Facebook
Twitter
Privacy Policy